 |
Nonpharmacologic Management of Osteoporosis to Minimize Fracture Risk CME DisclosuresRelease Date: December 18, 2007; Valid for credit through December 18, 2008 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| Nonpharmacologic therapies for osteoporosis, including orthoses, exercise, calcium and vitamin D, fall prevention, and kyphoplasty, complement pharmacotherapy in minimizing fracture risk and maximizing bone mineral density. In patients who cannot or who choose not to take antiosteoporotic medications, these interventions have a definitive role in treatment. - Nonpharmacologic Management of Osteoporosis to Minimize Fracture Risk
Julie T. Lin, MD
Joseph M. Lane, MD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2007 Medscape. |
|
|
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
